And The UK's First 'Innovation Passport' Goes To... MSD's Rare Disease Drug Belzutifan
Regulator Invites More Applications For New Pathway
Executive Summary
The MHRA is losing no time in getting its much heralded “new era” of medicines regulation up and running.
You may also be interested in...
Gilead’s Trodelvy To Test UK Innovative Drug Pathway
The cancer drug is also to undergo an accelerated assessment by the European Medicines Agency.
Keeping Track: Recent NDA Submissions Range From Acute Agitation To Von Hippel-Lindau Disease
News and highlights of applications submitted for US FDA approval, from the Pink Sheet’s FDA Performance Tracker
COVID-19 Strengthens Ties Between UK MHRA & NICE On Access To Innovation
New partnerships forged between the UK medicines regulator and health technology assessment bodies during COVID-19 have resulted in an improved understanding of the benefits new drugs can bring to the NHS and how to manage their rapid introduction.